Literature DB >> 7753701

Malignant wide complex tachycardia after adenosine administration to a postoperative pediatric patient with congenital heart disease.

G Kipel1, A F Rossi, L G Steinberg, B Gelb, F Fiumecaldo, R J Golinko, R B Griepp.   

Abstract

Adenosine has become the treatment of choice for paroxysmal supraventricular tachycardia because of its safety and efficacy. There have been no reports of malignant arrhythmias occurring after adenosine administration. This case report presents the occurrence of a malignant wide complex tachycardia after intravenous adenosine administration in a 10-year-old boy 2 days after a Fontan procedure. Thus the administration of adenosine in a critically ill postoperative patient can have morbidity or potential mortality and must be monitored closely.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753701     DOI: 10.1007/BF02310334

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  6 in total

1.  Use of adenosine in the management of perioperative arrhythmias in the pediatric cardiac intensive care unit.

Authors:  A F Rossi; L G Steinberg; G Kipel; R J Golinko; R B Griepp
Journal:  Crit Care Med       Date:  1992-08       Impact factor: 7.598

2.  Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.

Authors:  J P DiMarco; W Miles; M Akhtar; S Milstein; A D Sharma; E Platia; B McGovern; M M Scheinman; W C Govier
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

3.  Usefulness of adenosine for arrhythmias in infants and children.

Authors:  E D Overholt; K S Rheuban; H P Gutgesell; B B Lerman; J P DiMarco
Journal:  Am J Cardiol       Date:  1988-02-01       Impact factor: 2.778

4.  Electrophysiologic effects of adenosine-5'-triphosphate on atrioventricular reentrant tachycardia.

Authors:  B Belhassen; A Pelleg; D Shoshani; B Geva; S Laniado
Journal:  Circulation       Date:  1983-10       Impact factor: 29.690

5.  Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.

Authors:  J P DiMarco; T D Sellers; R M Berne; G A West; L Belardinelli
Journal:  Circulation       Date:  1983-12       Impact factor: 29.690

6.  Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5'-triphosphate, and verapamil: a comparative study.

Authors:  R Greco; B Musto; V Arienzo; A Alborino; S Garofalo; F Marsico
Journal:  Circulation       Date:  1982-09       Impact factor: 29.690

  6 in total
  1 in total

Review 1.  Safety issues in the treatment of paediatric supraventricular tachycardias.

Authors:  J P Pfammatter; U Bauersfeld
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.